Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults
PHASE1CompletedINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
December 5, 2022
Primary Completion Date
April 7, 2023
Study Completion Date
May 13, 2023
Conditions
Healthy
Interventions
DRUG
UPB-101
UPB-101 Subcutaneous injection
Trial Locations (1)
Unknown
Richmond Pharmacology, London
All Listed Sponsors
lead
Upstream Bio Inc.
INDUSTRY
NCT05653479 - Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults | Biotech Hunter | Biotech Hunter